Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
bitop AG
Dortmund, Nordrhein-Westfalen, Germanybitop.de ↗
- Ownership
- Private
- Employees
- ~42
- Development stage
- Other
01
Overview
Bitop has developed commercial products based on Ectoin® and other extremolytes. Clinical trials have shown Ectoin reduces symptoms of acute allergic rhinitis and may positively influence lung inflammation.
- Therapeutic areas
- OtherImmunologyDermatologyPulmonology
- Modalities
- ExtremolytesNatural compounds
- Industry
- Therapeutic Medical Devices
02
Partnerships
Merck KGaA (Darmstadt)Banxa
Beyond the preview
Go deeper on bitop AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bitop AG.